Patent · US Active

Quantification of vaccine compositions

US10767213B2 · kind B2 · utility

0Cited by
23References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2017
Grant dateSep 8, 2020
Priority date
Expiry dateApr 9, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/01
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides methods and mass-labeled peptides for use in said methods for quantifying the presence of a one or more viral proteins in a sample of a preparation containing agents which bind to said viral protein, using mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides, in particular wherein said viral proteins are antigens in a vaccine for porcine circovirus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.